- 250 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Overcoming Cancers Resistant to HER-2 Antibodies
About this book
Overcoming Cancers Resistant to HER-2 Antibodies provides general updated information on the resistance of various human cancers to anti-HER2 therapeutic antibodies. The book also discusses the description of various sensitizing agents that can reverse resistance when used in combination with anti-HER2 antibodies. There have been a lot of reports in which the treatment with anti-HER2 antibodies for various cancers has resulted in clinical responses; however, there have been also subsets of cancer patients who did not respond initially, and several responding patients developed resistance following treatments. Sections cover Lapatinib, Ganetespib, Paclitaxel, Celecoxib, Emantasine, Liposomal Doxorubicin, and Kinase Inhibitors.This book is a valuable source for cancer researchers, oncologists, pharmacologists and different members of the biomedical field interested in fighting cancer resistance to HER-2 antibodies.
- Provides a general summary of various sensitizing agents that can work effectively when used in combination with anti-HER2 antibodies to reverse resistance
- Offers potential underlying mechanisms by which cancer cells are either inherently resistant or become unresponsive to antibody treatment
- Discusses how to develop new targeted agents to underlie resistance in order to expand research on this field
Trusted byĀ 375,005 students
Access to over 1.5 million titles for a fair monthly price.
Study more efficiently using our study tools.
Information
Table of contents
- Title of Book
- Cover image
- Title page
- Table of Contents
- Copyright
- Cover image insert
- Aims and scope of series āBreaking tolerance to antibody-targeted therapiesā
- About the Series Editor
- Aims and scope of the volume āOvercoming Cancers Resistant to HER-2 Antibodiesā
- Preface āOvercoming Cancers Resistant to HER-2 Antibodiesā
- Contributors
- Chapter 1 Resistance of breast cancer brain metastasis to trastuzumab therapy
- Chapter 2 Resistance of HER2-expressing breast cancer patients treated with trastuzumab: Underlying mechanisms of resistance and reversals
- Chapter 3 Understanding mechanisms of resistance to HER2-targeted therapies in HER2-positive breast cancer
- Chapter 4 Clinical implications and management strategies of resistance to anti-HER2 antibodies in breast cancer
- Chapter 5 Overexpression of antiapoptotic gene products and resistance to trastuzumab treatment of breast cancer
- Chapter 6 How does understanding epigenetics help circumvent HER-2 antibody resistance?
- Chapter 7 Resistance of HER2-expressing ovarian cancer to trastuzumab and mechanisms of overcoming resistance
- Chapter 8 Clinical implications of resistance to anti-HER2 antibodies in breast cancer
- Chapter 9 Highlights of current and future for the treatment of resistant HER2+ breast cancer to HER2-targeted therapies
- Index
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn how to download books offline
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.5M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1.5 million books across 990+ topics, weāve got you covered! Learn about our mission
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more about Read Aloud
Yes! You can use the Perlego app on both iOS and Android devices to read anytime, anywhere ā even offline. Perfect for commutes or when youāre on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app
Yes, you can access Overcoming Cancers Resistant to HER-2 Antibodies by Benjamin Bonavida in PDF and/or ePUB format, as well as other popular books in Medicine & Pharmaceutical, Biotechnology & Healthcare Industry. We have over 1.5 million books available in our catalogue for you to explore.